Physician profile
Michelle Levy
NPI 1235224080
$2,279.70
in general payments reported to CMS, 2019-2025
17 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.73 · 2020: $269 · 2021: $367 · 2022: $431 · 2023: $290 · 2024: $565 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $631.04 | 2019-2025 | Dailies Total1, Precision 1, Precision7 |
| Biotissue Holdings INC. | $339.11 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $207.08 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $181.92 | 2020-2021 | |
| Oyster Point Pharma, INC. | $172.24 | 2022-2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $139.28 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $135.70 | 2022-2025 | Infuse, Miebo, Xiidra |
| Dompe US, INC. | $113.74 | 2021-2024 | Oxervate |
| Horizon Therapeutics Plc | $81.96 | 2022-2023 | Uplizna |
| Allergan, INC. | $76.48 | 2020-2022 | |
| Sight Sciences, INC. | $62.00 | 2022-2024 | Tearcare System |
| Abb Con-Cise Optical Group LLC | $34.28 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $25.96 | 2019-2020 | |
| Coopervision INC. | $23.08 | 2022 | |
| Oasis Medical, INC. | $22.12 | 2020-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $20.26 | 2022 | |
| Maculogix, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.